+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Anaphylaxis Market, Food Reaction Testing by Food Sources, Treatment & Services, Age group, Urban & Rural, End Users, Forecast

  • PDF Icon

    Report

  • 205 Pages
  • March 2021
  • Region: United States
  • Renub Research
  • ID: 5308271
Anaphylaxis is a severe and potentially fatal allergic reaction. It is a life-threatening reaction with respiratory, cardiovascular, cutaneous, or gastrointestinal manifestations. The bulk habitual anaphylactic reaction is caused by foods, insect stings, medications and latex. People with hypersensitive to things in their environment, their immune responses overreact to an antigen by discharging chemicals that cause allergy reaction. Anaphylaxis food reaction could be vital and cause death if the prior management not taken. According to the publisher, United States Anaphylaxis Market was 5.3 Billion in 2027.

As per the analysis, in the United States, due to anaphylaxis reaction to foods say Eggs, Milk Products, Crustaceans, Fish, Food Additives, Peanuts, Tree nuts/seeds, the death rate frequency increases with every passing year. However, this leads to an increment in the number of patients. Approximately 1,500 deaths in the United States happen every year due to anaphylaxis. From 2009 to 2016, the percentage of claims due to food allergy diagnoses was more vital than any other state's medical claims. Besides, North Carolina State has the highest rate in 2016 compared to the low percent in 2009. The United States Anaphylaxis Market is expected to grow with a double-digit CAGR of 11.98% during 2020-2027.

The food allergy with the highest average cost and service per patient in 2016 was due to milk products. The United States government authorities and bodies were regularly planning and giving awareness tips. Treatment of anaphylaxis is primarily related to Office or O.P. Services. Patients in the United States consider outpatient emergencies for primary diagnosis and symptoms management. In the United States, Anaphylactic Allergens are more in rural areas as compare to Urban.

The factors driving the United States Anaphylaxis Market are the surge in Allergic Reactions, International Trade & Commerce of Food Materials. However, there are few challenges like a Lack of Awareness & Food Control Infrastructure and Food Control Authorities for this market. As per this research study, United States Anaphylaxis Market was worth US$ 2.4 Billion in 2020.

Deals in Companies

Mérieux Nutri Sciences expands capabilities in environmental analyses with C.P.G. Lab in Italy
Eurofins acquires L.A.B. Solution, thereby reinforcing its footprint in the Textile and Leather industries.
Food Label Regulations in the United States that all packaged foods regulated by F.D.A. under the FD&C Act that are labelled on or after 1 January 2006 must obey food allergen labelling requirements.

This is a must purchase report to get the full picture of the United States Anaphylaxis Market. The report shows that the prevalence of anaphylaxis in the United States' general population is the least of the people; however, growing probably higher.

The publisher studied the “United States Anaphylaxis Market, Food Reaction Testing by Food Sources (Peanuts, Tree nuts/seeds, Eggs, Milk Products, Crustaceans, Fish, Food Additives, Fruits/Vegetables and Others specific foods) Treatment & Services (Immunology Services, Allergen Testing, Venipunctures, Office or O.P. Services New Patient, Ingestion Challenge Testing, Drugs Administered Other than Oral, Office or O.P. Services Established Patient, Therapeutic, Prophylactic, and Dx Injection/Infusions, Chemistry Tests, E.D. New or Estab Patients, Office or Other O.P. Consults, Pulmonary Diagnostic Testing and Therapies, Inpatient Visits, All Others) Anaphylaxis reaction to peanuts, crustaceans by Age group (0-3 years to Over 60 years), (Urban & Rural) End Users (Laboratory, Emergency Room, Inpatients, Outpatients, Office, Others)” provides current trends of the United States Anaphylaxis Industry.

Market & Patient Numbers of United States Anaphylaxis Food Reaction has been covered from two viewpoints:
  • Testing Market
  • Diagnose Patient Numbers

Treatments & Services - Market breakup from 14 Viewpoints

1. Immunology Services
2. Allergen Testing
3. Venipunctures
4. Office or O.P. Services New Patient
5. Ingestion Challenge Testing
6. Drugs Administered Other Than Oral
7. Office or O.P. Services Established Patient
8. Therapeutic, Prophylactic, and Dx Injection/Infusions
9. Chemistry Tests
10. E.D. New or Estab Patients
11. Office or Other O.P. Consults
12. Pulmonary Diagnostic Testing and Therapies
13. Inpatient Visits
14. All Others

Food Sources - Market breakup from 9 Viewpoints

1. Peanuts
2. Tree nuts/seeds
3. Eggs
4. Milk Products
5. Crustaceans
6. Fish
7. Food Additives
8. Fruits/Vegetables
9. Other Specific Foods

Segment - Patient Numbers in 9 Age Groups

1. Peanuts
2. Crustaceans
3. Food Additives

Age Group - Patients Diagnose Numbers

1. Age Groups 0 to 3
2. Age Groups 4 to 5
3. Age Groups 6 to 10
4. Age Groups 11 to 18
5. Age Groups 19 to 30
6. Age Groups 31 to 40
7. Age Groups 41 to 50
8. Age Groups 51 to 60
9. Over 60

Rural & Urban - Market & Patient Numbers from 2 Viewpoints

1. Rural Market & Patient Numbers
2. Urban Market & Patient Numbers

End Users - Market breakup from 6 Viewpoints

1. Laboratory
2. Emergency Room
3. Inpatient
4. Out Patient
5. Food Office
6. All Others

Table of Contents

1. Introduction2. Research & Methodology3. Executive Summary4. Food Label Regulations in the United States
5. Market Dynamics
5.1 Growth Drivers
5.2 Challenges
6. United States Anaphylaxis Market & Patient Numbers
6.1 Market
6.2 Diagnose Patient Volume
7. Market Share Analysis
7.1 Rural Vs. Urban
8. Treatments & Services - United States Anaphylaxis Market
8.1 Immunology Services
8.2 Allergen Testing
8.3 Venipunctures
8.4 Office or O.P. Services New Patient
8.5 Ingestion Challenge Testing
8.6 Drugs Administered Other Than Oral
8.7 Office or O.P. Services Established Patient
8.8 Therapeutic,Prophylactic, and Dx Injection/Infusions
8.9 Chemistry Tests
8.10 E.D. New or Estab Patients
8.11 Office or Other O.P. Consults
8.12 Pulmonary Diagnostic Testing and Therapies
8.13 Inpatient Visits
8.14 Others
9. Food Sources - United States Anaphylaxis Market
9.1 Peanuts
9.2 Tree nuts/seeds
9.3 Eggs
9.4 Milk Products
9.5 Crustaceans
9.6 Fish
9.7 Food Additives
9.8 Fruits/Vegetables
9.9 Other Specific Foods
10. Age Group Patient Numbers - United States Anaphylaxis
10.1 Peanuts (9 Categories of Age Group)
10.2 Crustaceans (9 Categories of Age Group)
10.3 Food Additives (9 Categories of Age Group)
11. Rural & Urban - United States Anaphylaxis
11.1 Rural
11.1.1 Market
11.1.2 Patient Numbers
11.2 Urban Market
11.2.1 Market
11.2.2 Patient Numbers
12. End Users - United States Anaphylaxis Market
12.1 Laboratory
12.2 Emergency Room
12.3 Inpatient
12.4 Out Patient
12.5 Food Office
12.6 Others
List of Figures:
Figure-01: Percentage of children aged 0-17 years with a reported allergic condition in the past 12 months: United States, 1997-2011
Figure-02: United States - Anaphylactic Food Reaction Testing Market (Million US$), 2016 - 2020
Figure-03: United States - Forecast for Anaphylactic Food Reaction Testing Market (Million US$), 2021 - 2027
Figure-04: United States - Anaphylactic Food Reaction Diagnose (Number), 2016 - 2020
Figure-05: United States - Forecast for Anaphylactic Food Reaction Diagnose (Number), 2021 - 2027
Figure-06: United States - Anaphylactic Food Reaction Test Market Share by Urban & Rural (Percent), 2020
Figure-07: United States - Immunology Services (Million US$), 2016 - 2020
Figure-08: United States - Forecast for Immunology Services (Million US$), 2021 - 2027
Figure-09: United States - Allergen Testing (Million US$), 2016- 2020
Figure-10: United States - Forecast for Allergen Testing (Million US$), 2021 - 2027
Figure-11: United States - Venipunctures Test (Million US$), 2016 - 2020
Figure-12: United States - Forecast for Venipunctures Test (Million US$), 2021 - 2027
Figure-13: United States - Office or O.P. Services New Patient (Million US$), 2016 - 2020
Figure-14: United States - Forecast for Office or O.P. Services New Patient (Million US$), 2020 - 2027
Figure-15: United States - Ingestion Challenge Testing (Million US$), 2016 - 2020
Figure-16: United States - Forecast for Ingestion Challenge Testing (Million US$), 2021 - 2027
Figure-17: United States - Drugs Administered Other Than Oral (Million US$), 2016 - 2020
Figure-18: United States - Forecast for Drugs Administered Other Than Oral (Million US$), 2021 - 2027
Figure-19: United States - Office or O.P. Services Established Patient (Million US$), 2016 - 2020
Figure-20: United States - Forecast for Office or O.P. Services Established Patient (Million US$), 2021 - 2027
Figure-21: United States - Therapeutic, Prophylactic, and Dx Injection/Infusions (Million US$), 2016 - 2020
Figure-22: United States - Forecast for Therapeutic, Prophylactic, and Dx Injection/Infusions (Million US$), 2021 - 2027
Figure-23: United States - Chemistry Tests (Million US$), 2016 - 2020
Figure-24: United States - Forecast for Chemistry Tests (Million US$), 2021 - 2027
Figure-25: United States - E.D. New or Estab Patients (Million US$), 2016 - 2020
Figure-26: United States - Forecast for E.D. New or Estab Patients (Million US$), 2021 - 2027
Figure-27: United States - Office or Other O.P. Consults (Million US$), 2016 - 2020
Figure-28: United States - Forecast for Office or Other O.P. Consults (Million US$), 2021 - 2027
Figure-29: United States - Pulmonary Diagnostic Testing and Therapies (Million US$), 2016 - 2020
Figure-30: United States - Forecast for Pulmonary Diagnostic Testing and Therapies (Million US$), 2021 - 2027
Figure-31: United States - Inpatient Visits (Million US$), 2016 - 2020
Figure-32: United States - Forecast for Inpatient Visits (Million US$), 2021 - 2027
Figure-33: United States - All Others Test (Million US$), 2016 - 2020
Figure-34: United States - Forecast for All Others Test (Million US$), 2021 - 2027
Figure-35: United States - Pea Nuts Reaction Market (Million US$), 2016 - 2020
Figure-36: United States - Forecast for Pea Nuts Reaction Market (Million US$), 2021 - 2027
Figure-37: United States - Tree Nuts/Seeds Reaction Market (Million US$), 2016 - 2020
Figure-38: United States - Forecast for Tree nuts/seeds reaction Market (Million US$), 2021 - 2027
Figure-39: United States - Eggs reaction Market (Million US$), 2016 - 2020
Figure-40: United States - Forecast for Eggs reaction Market (Million US$), 2021 - 2027
Figure-41: United States - Milk Products Reaction Market (Million US$), 2016 - 2020
Figure-42: United States - Forecast for Milk Products Reaction Market (Million US$), 2021 - 2027
Figure-43: United States - Crustaceans Reaction Market (Million US$), 2016 - 2020
Figure-44: United States - Forecast for Crustaceans Reaction Market (Million US$), 2021 - 2027
Figure-45: United States - Fish Reaction Market (Million US$), 2016 - 2020
Figure-46: United States - Forecast for Fish Reaction Market (Million US$), 2021 - 2027
Figure-47: United States - Food Additives Reaction Market (Million US$), 2016 - 2020
Figure-48: United States - Forecast for Food Additives Reaction Market (Million US$), 2021 - 2027
Figure-49: United States - Fruits/Vegetables Reaction Market (Million US$), 2016 - 2020
Figure-50: United States - Forecast for Fruits/Vegetables Reaction Market (Million US$), 2021 - 2027
Figure-51: United States - Other Specific Foods Reaction Market (Million US$), 2016 - 2020
Figure-52: United States - Forecast for Other Specific Foods Reaction Market (Million US$), 2021 - 2027
Figure-53: United States - Anaphylactic Food reaction Rural Market (Million US$), 2016 - 2020
Figure-54: United States - Forecast for Anaphylactic Food reaction Rural Market (Million US$), 2021 - 2027
Figure-55: United States - Anaphylactic Food Reaction Urban Market (Million US$), 2016 - 2020
Figure-56: United States - Forecast for Anaphylactic Food Reaction Urban Market (Million US$), 2021 - 2027
Figure-57: United States - Anaphylactic Food Reaction Rural Patients (Number), 2016 - 2020
Figure-58: United States - Forecast for Anaphylactic Food Reaction Rural Patients (Number), 2021 - 2027
Figure-59: United States - Anaphylactic Food Reaction Urban Patients (Number), 2016 - 2020
Figure-60: United States - Forecast for Anaphylactic Food Reaction Urban Patients (Number), 2021 - 2027
Figure-61: United States - Anaphylactic Food Reaction Laboratory Market (Million US$), 2016 - 2020
Figure-62: United States - Forecast for Anaphylactic Food reaction Laboratory Market (Million US$), 2021 - 2027
Figure-63: United States - Anaphylactic Food Allergen Market by Emergency Room (Million US$), 2016 - 2020
Figure-64: United States - Forecast for Anaphylactic Food Allergen Market by Emergency Room (Million US$), 2021 - 2027
Figure-65: United States - Anaphylactic Food Allergen Market by Inpatient (Million US$), 2016 - 2020
Figure-66: United States - Forecast for Anaphylactic Food Allergen Market by Inpatient (Million US$), 2020 - 2027
Figure-67: United States - Anaphylactic Food Allergen Market by Outpatient (Million US$), 2016 - 2020
Figure-68: United States - Forecast for Anaphylactic Food Allergen Market by Outpatient (Million US$), 2021 - 2027
Figure-69: United States - Anaphylactic Food Allergen Market by Office (Million US$), 2016 - 2020
Figure-70: United States - Forecast for Anaphylactic Food Allergen Market by Office (Million US$), 2021 - 2027
Figure-71: United States - Anaphylactic Food Allergen Market by All Others (Million US$), 2016 - 2020
Figure-72: United States - Forecast for Anaphylactic Food Allergen Market by All Others (Million US$), 2021 - 2027
List of Tables:
Table-01: Top 10 Exporters and Importers of Food, 2017 (Billion dollars and Percentage)
Table-02: United States - Anaphylactic Reaction to Peanuts by Age Group 0 to 3 to Over 60 years (Number), 2016 - 2020
Table-03: United States - Forecast for Anaphylactic Reaction to Peanuts by Age Group 0 to 3 to Over 60 years (Number), 2021 - 2027
Table-04: United States - Anaphylactic Reaction to Crustaceans by Age Group 0 to 3 to Over 60 years (Number), 2016 - 2020
Table-05: United States - Forecast for Anaphylactic Reaction to Crustaceans by Age Group 0 to 3 to Over 60 years (Number), 2021 - 2027
Table-06: United States - Anaphylactic Reaction to Food Additives by Age Group Age Groups 0 to 3 years to Over 60 years (Number), 2016 - 2020
Table-07: United States - Forecast for Anaphylactic Reaction to Food Additives by Age Group Age Groups 0 to 3 years to Over 60 years (Number), 2021 - 2027

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...